Insights from patients screened but not randomised in the HYPERION trial
Jean-Baptiste Lascarrou(Centre Hospitalier Universitaire de Nantes), Stéphane Legriel(Inserm), Grégoire Müller(Centre hospitalier régional d'Orléans), Jean Reignier(Centre Hospitalier Universitaire de Nantes), Mickaël Landais, Didier Thévenin(Centre Hospitalier de Lens), Pierre Asfar(Centre Hospitalier Universitaire d'Angers), Jean-Charles Chakarian, Jean‐Pierre Frat(Inserm), Guillaume Grillet(Université de Bordeaux), Nicolas Massart(Centre Hospitalier de Saint-Brieuc), Gwenhaël Colin(Assistance Publique – Hôpitaux de Paris), Jean‐Pierre Quenot(Inserm), Bruno François(Inserm), Michel Sirodot(Centre Hospitalier Annecy Genevois), Sylvie Vimeux, Arnaud Delahaye(Assistance Publique – Hôpitaux de Paris)
Cited by 8
Related Papers
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890